UiPath (PATH) Faces A Valuation Test As Slower Growth Meets A Sharp Rebound

Recent commentary on UiPath (PATH) has focused on a slowdown in its revenue growth compared with its longer term trend. This has prompted a more cautious tone around demand and future expectations for the stock.

See our latest analysis for UiPath.

Against this backdrop, UiPath’s recent share price momentum has been strong, with a 30 day share price return of 28.85% and a 90 day share price return of 50.35%. This comes even though the year to date share price return is down 5.23% and the five year total shareholder return is down 74.93%.

If you want to see what else is moving in automation and AI, it could be worth scanning 37 robotics and automation stocks.

So is this sharp rebound in UiPath a sign that investors are re-rating the underlying automation business, or more a swing in sentiment after a tough few years? The valuation is where that tension shows up most clearly.

Most Popular Narrative: 13.1% Overvalued

UiPath’s most followed narrative points to a fair value of $13.31 compared with the recent $15.05 share price, which puts the current rally in a different light.

UiPath's focus on accelerating innovation across the agentic automation road map is expected to grow deeper customer relationships and strategic partnerships, likely driving future revenue growth. Increased adoption of UiPath's platform among existing customers, supported by strategic changes in the go-to-market structure, is aimed at enhancing customer engagement and boosting ARR growth.

Read the complete narrative.

Want to see what has to happen for that fair value to stack up? The narrative leans heavily on automation driven ARR, shifting margins, and a higher earnings multiple. The exact mix of growth, profitability, and valuation expectations might surprise you.

Result: Fair Value of $13.31 (OVERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, UiPath still faces softer net new ARR and uncertainty around customer budgets, which could challenge the more optimistic earnings and P/E assumptions in that narrative.

Find out about the key risks to this UiPath narrative.

Another View On UiPath Using Earnings Multiples

The DCF style fair value of $13.31 suggests UiPath is 13.1% overvalued at $15.05. Yet on a simple P/E basis the story looks different. UiPath trades on 23.8x earnings compared with 32.5x for the US Software industry and 37.7x for close peers, and is below a fair ratio of 27.1x. That combination of a discount on earnings and a premium to DCF leaves a clear question for investors: Which yardstick carries more weight for you right now?

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With the mixed tone around UiPath in mind, it may be useful to move quickly, review the underlying data, and pressure test the potential upside case for yourself by checking the 3 key rewards.

Looking for more investment ideas beyond UiPath?

If UiPath has you thinking more seriously about your portfolio, do not stop here. Use the Simply Wall Street Screener to explore other focused opportunities.

• Review the 52 high quality undervalued stocks to find quality companies that are trading below their assessed value.
• Use the 8 dividend fortresses to assess companies with resilient payouts and support your income stream.
• Apply the 83 resilient stocks with low risk scores to filter for companies with steadier risk profiles and emphasise capital protection.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com